ASEP Medical Holdings Inc.
SEPSF
$0.01
-$0.38-97.18%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.35% | 70.84% | 202.98% | 1,301.29% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.35% | 70.84% | 202.98% | 1,301.29% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 18.35% | 70.84% | 202.98% | 1,301.29% | -- |
| SG&A Expenses | -42.32% | -49.68% | -38.22% | -38.61% | -8.53% |
| Depreciation & Amortization | -36.89% | -25.35% | -13.72% | -0.82% | 0.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.61% | -45.47% | -36.12% | -36.16% | -18.25% |
| Operating Income | 44.94% | 49.29% | 40.17% | 40.76% | 22.56% |
| Income Before Tax | -127.38% | -108.62% | -69.73% | -48.43% | 34.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -127.38% | -108.62% | -69.73% | -48.43% | 33.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 461.06% | 422.57% | 374.98% | 336.32% | -31.66% |
| Net Income | -64.47% | -50.33% | -19.62% | -3.75% | 34.01% |
| EBIT | 44.94% | 49.29% | 40.17% | 40.76% | 22.56% |
| EBITDA | 48.63% | 57.63% | 48.36% | 51.70% | 29.36% |
| EPS Basic | -43.24% | -28.69% | 0.58% | 16.18% | 45.09% |
| Normalized Basic EPS | 240.70% | 211.91% | 178.31% | 165.74% | 34.28% |
| EPS Diluted | -43.24% | -28.69% | 0.58% | 16.18% | 45.09% |
| Normalized Diluted EPS | 240.70% | 211.91% | 178.31% | 165.74% | 34.28% |
| Average Basic Shares Outstanding | 28.82% | 22.31% | 17.52% | 22.18% | 23.21% |
| Average Diluted Shares Outstanding | 28.82% | 22.31% | 17.52% | 22.18% | 23.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |